An initial report of cyberknife radiosurgery treatment in early stage lung cancer
- VernacularTitle:射波刀治疗早期周围型肺癌结果的初步分析
- Author:
Zhiyong YUAN
;
Yongchun SONG
;
Fengtong LI
;
Yang DONG
;
Jingsheng WANG
;
Jun WANG
;
Changli WANG
;
Ping WANG
- Publication Type:Journal Article
- Keywords:
Lung neoplasms/stereotactic radiotherapy;
Cyberknife;
Short-time outcome
- From:
Chinese Journal of Radiation Oncology
2008;17(3):180-183
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy and toxicity of the cyberknife in the treatment of medically inoperable patients with early stage lung cancer. Methods From September 2006 to July 2007,17 patients with clinical stage Ⅰ a- Ⅰ b lung cancer were treated with cyberknife at Tianjin Cancer Hospital. Of the 11 patients receiving CT guided biopsy, 3 were squamous cell cancer and 8 were adenocarcinoma. Six patients refused intrusive operation and were diagnosed by PET-CT scan. All patients were medically inoperable evaluated by a thoracic surgeon. The PTV = GTV + 3 ～ 5 mm, and the median volume of PTV was 36 cm3 (6-82 cm3 ). The median total prescription dose was 50 Gy(45-60 Gy) at 3-5 fractions. Results The median follow-up time was 7 months (3-11 months). All the patients finished the treatment and were alive by the last follow-up. Slight fatigue was the most common complain. Evaluated by CT scan, 13 were complete response and 4 were partial response. No recurrence, progression or distant metastasis occured. There were 3 patients with grade Ⅰ granulocytopenia,3 grade Ⅰ pneumonitis and 1 grade Ⅱ pneumonitis. Conclusions The cyberknife radiosurgery treatment in early stage lung cancer shows a high rate of local control and minimal toxicity. Long time follow-up is necessary to evaluate the survival data and late toxicity.
